Key facts
- · Type: Amendment first sale 2024-11-04 · Amount sold: $6.47M · Total offering: $20M · SEC filing
- · Type: Amendment first sale 2024-11-04 · Amount sold: $6.47M · Total offering: $12M · SEC filing
- · Type: Filing · SEC filing
- · Type: Filing · SEC filing
- · Type: Amendment · SEC filing
Is SYNDEVRX INC a real, registered company?
SYNDEVRX INC is a registered filer with the SEC (CIK 1455364) and has filed since 2022-12-14. 6 filings are on record, the latest on 2025-12-23.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Run the free check on SYNDEVRX INC →
CAMBRIDGE, MASSACHUSETTS
Biotechnology
6
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2025-12-23 | Amendment first sale 2024-11-04 | $6.47M | $20M | SEC filing |
| 2025-11-17 | Amendment first sale 2024-11-04 | $6.47M | $12M | SEC filing |
| 2024-11-15 | Filing | — | — | SEC filing |
| 2024-10-10 | Filing | — | — | SEC filing |
| 2023-12-20 | Amendment | — | — | SEC filing |
| 2022-12-14 | Amendment | — | — | SEC filing |
Watch SYNDEVRX INC
Get an email when SYNDEVRX INC files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with SYNDEVRX INC?
Who to contact
- Bradley Carver — Executive Officer, Director
- James Shanahan — Executive Officer, Director
- Charles Flynn — Director
- Jeffrey Welles — Director
- Michael Clifford — Director
- David Neafus — Executive Officer
- Round: Form D/A (amended) filed 2025-12-23
- Amount sold: $6.47M
- Industry: Biotechnology
- Based: CAMBRIDGE, MASSACHUSETTS
People listed
- Bradley Carver — Executive Officer, Director
- James Shanahan — Executive Officer, Director
- Charles Flynn — Director
- Jeffrey Welles — Director
- Michael Clifford — Director
- David Neafus — Executive Officer
- Filing: Form D/A (amended) filed 2025-12-23
- Amount sold: $6.47M
- Industry group: Biotechnology
- Based: CAMBRIDGE, MASSACHUSETTS
- Entity type: Corporation
We'll show it in your MentionFox inbox when SYNDEVRX INC raises, hires or launches. No email unless you switch it on.
Watch SYNDEVRX INC →Want the whole picture on SYNDEVRX INC?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on SYNDEVRX INC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on SYNDEVRX INC covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
7 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Every figure here is read from SYNDEVRX INC's own filings with the SEC. The people those filings name are on the team page.